Vor Biopharma (VOR) Other Accumulated Expenses (2020 - 2026)
Vor Biopharma (VOR) reported Other Accumulated Expenses of $698000.0 for Q1 2026, up 6.4% year-over-year from $656000.0 in Q1 2025, and up 25.99% on a QoQ basis from $554000.0 in Q4 2025.
Vor Biopharma (VOR) has 7 years of Other Accumulated Expenses data on file, last reported at $698000.0 in Q1 2026.
- Quarterly Other Accumulated Expenses rose 6.4% year-over-year to $698000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $698000.0 (up 6.4% YoY) and the FY2025 annual result came in at $554000.0, up 55.62% from the prior year.
- Other Accumulated Expenses rose to $698000.0 in Q1 2026 per VOR's latest filing, from $554000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $2.4 million in Q3 2023 and bottomed at $25000.0 in Q2 2024.
- The 5-year median for Other Accumulated Expenses is $351000.0 (2022), against an average of $558647.1.
- The widest annual swing landed in 2023, when Other Accumulated Expenses jumped 909.87%; it then plunged 94.71% in 2024.
- Tracing VOR's Other Accumulated Expenses over 5 years: stood at $351000.0 in 2022, then slipped by 21.94% to $274000.0 in 2023, then rose by 29.93% to $356000.0 in 2024, then surged by 55.62% to $554000.0 in 2025, then increased by 25.99% to $698000.0 in 2026.
- Per Business Quant, the three latest VOR Other Accumulated Expenses figures stand at $698000.0 (Q1 2026), $554000.0 (Q4 2025), and $35000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vor Biopharma | 628.83 Mn | 628.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 698,000.00 |
| Dec 31, 2025 | 554,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 656,000.00 |
| Dec 31, 2024 | 356,000.00 |
| Sep 30, 2024 | 272,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 592,000.00 |
| Dec 31, 2023 | 274,000.00 |
| Sep 30, 2023 | 2.35 Mn |
| Jun 30, 2023 | 473,000.00 |
| Mar 31, 2023 | 179,000.00 |
| Dec 31, 2022 | 351,000.00 |
| Sep 30, 2022 | 233,000.00 |
| Jun 30, 2022 | 2.01 Mn |
| Mar 31, 2022 | 351,000.00 |
| Dec 31, 2021 | 797,000.00 |
| Sep 30, 2021 | 173,000.00 |
| Jun 30, 2021 | 1.04 Mn |
| Mar 31, 2021 | 675,000.00 |
| Dec 31, 2020 | 723,000.00 |